(Q39298930)

10 September 2017

title

Wnt pathway activity confers chemoresistance to cancer stem-like cells in a neuroblastoma cell line (English)

1 reference

10 September 2017

0 references

1 reference

Sharada D Vangipuram

1

1 reference

10 September 2017

Steven A Buck

series ordinal

2

1 reference

10 September 2017

William D Lyman

series ordinal

3

1 reference

10 September 2017

publication date

11 August 2012

1 reference

10 September 2017

1 reference

10 September 2017

volume

33

1 reference

10 September 2017

issue

6

1 reference

10 September 2017

page(s)

2173-2183

1 reference

A population-based study of neuroblastoma incidence, survival, and mortality in North America.

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

Neuroblastoma cell lines contain pluripotent tumor initiating cells that are susceptible to a targeted oncolytic virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

Cancer stem cells: the theory and perspectives in cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

Cancer stem cells: the emerging challenge of drug targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

Recent advances in cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

Identification of human brain tumour initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

Role of stemness-related molecules in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

Genotype analysis of tumor-initiating cells expressing CD133 in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

Functional sphere profiling reveals the complexity of neuroblastoma tumor-initiating cell model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

Resistance of stem-like cells from neuroblastoma cell lines to commonly used chemotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

CD133 expression is associated with poor outcome in neuroblastoma via chemoresistance mediated by the AKT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

Inhibition of the sonic hedgehog pathway by cyplopamine reduces the CD133+/CD15+ cell compartment and the in vitro tumorigenic capability of neuroblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

Association of telomerase activity with radio- and chemosensitivity of neuroblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

Stem-like cancer cells are inducible by increasing genomic instability in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

NEU4L sialidase overexpression promotes β-catenin signaling in neuroblastoma cells, enhancing stem-like malignant cell growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

Small molecule antagonists of the Wnt/β-catenin signaling pathway target breast tumor-initiating cells in a Her2/Neu mouse model of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

Role of Wnt/β-catenin signaling in drug resistance of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

Stem cell pathways contribute to clinical chemoresistance in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

Resistance or sensitivity of Wilms' tumor to anti-FZD7 antibody highlights the Wnt pathway as a possible therapeutic target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

Wnt activation is implicated in glioblastoma radioresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

Mitogen-activated protein kinase phosphatase-1 is required for cisplatin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

Ethanol alters cell fate of fetal human brain-derived stem and progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

Wnt signalling in stem cells and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

Protein kinase C in Wnt signaling: implications in cancer initiation and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

Role of canonical Wnt signaling in endometrial carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

Enhancement of canonical Wnt/β-catenin signaling activity by HCV core protein promotes cell growth of hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

Aberrant nuclear localization of EBP50 promotes colorectal carcinogenesis in xenotransplanted mice by modulating TCF-1 and β-catenin interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

Regulation of Lrp6 phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

Initiation of Wnt signaling: control of Wnt coreceptor Lrp6 phosphorylation/activation via frizzled, dishevelled and axin functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

Wnt induces LRP6 signalosomes and promotes dishevelled-dependent LRP6 phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

Wnt3 gene expression promotes tumor progression in non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

Frizzled 4 regulates stemness and invasiveness of migrating glioma cells established by serial intracranial transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

FZD4 as a mediator of ERG oncogene-induced WNT signaling and epithelial-to-mesenchymal transition in human prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

Dysregulation of Frizzled 6 is a critical component of B-cell leukemogenesis in a mouse model of chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

Expression of Wnt4 in human pituitary adenomas regulates activation of the beta-catenin-independent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

Frizzled receptor 6 marks rare, highly tumourigenic stem-like cells in mouse and human neuroblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

Temporal blastemal cell gene expression analysis in the kidney reveals new Wnt and related signaling pathway genes to be essential for Wilms' tumor onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

Expression profile of frizzled receptors in human medulloblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

Molecular origins of cancer: Molecular basis of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

Markers of the APC/β-catenin signaling pathway as potential treatable, preneoplastic biomarkers of risk for colorectal neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

Targeted inhibition of T-cell factor activity promotes syndecan-2 expression and sensitization to doxorubicin in osteosarcoma cells and bone tumors in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

ICG-001, a novel small molecule regulator of TCF/beta-catenin transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

The gamma catenin/CBP complex maintains survivin transcription in β-catenin deficient/depleted cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0478-0

SiRNA-mediated silencing of beta-catenin suppresses invasion and chemosensitivity to doxorubicin in MG-63 osteosarcoma cells

21 January 2018

1 reference

12 December 2020

A distinct "side population" of cells in human tumor cells: implications for tumor biology and therapy

1 reference

12 December 2020

Analysis of stemness gene expression and CD133 abnormal methylation in neuroblastoma cell lines

1 reference

12 December 2020

Disruption of the non-canonical WNT pathway in lung squamous cell carcinoma

1 reference

12 December 2020

10.1007/S13277-012-0478-0

Identifiers

DOI

1 reference

10 September 2017

1 reference